<table><tr><th>From:</th><th>Peter Attia</th></tr><tr><td>Sent:</td><td>Wednesday, September 16, 2015 4:15 AM</td></tr><tr><td>To:</td><td>jeffrey E.</td></tr><tr><td>Cc:</td><td>Bernard Kruger</td></tr><tr><td>Subject:</td><td>CoQ10</td></tr></table>

Bernie, with your blessing, I'= like Jeffry to take 300 mg of CoQ10 in the AM and 300 mg in the PM.

I'm fond of this formulation: http://www.amazon.com/NatureWise-Ubiqinol-Clinically-Tested-Kaneka/dp/B00E=VQ3BA/ref=sr_1_1?s=hpc&ie=UTF8&qid=1442376773&sr=1-1=amp;keywords=ubiquinol <http://www.amazon.com/NatureWise-Ubiqinol-Clinically-Tested-Kan=ka/dp/B00EFVQ3BA/ref=sr_1_1?s=hpc&ie=UTF8&qid=1442376773&a=p;sr=1-1&keywords=ubiquinol>

Hoping this increases statin toleran=e as we ponder PCSK9i.

Peter

<u>Peter Attia</u> <u><</u> <u>= an></u> I Nutrition Science Initiative (NuSI)<http://www.nusi.=rg/> I President

www.nusi.org

Confidentiality Notice: This e-mail is confidential and intended only f=r the recipients listed above. If you have received this e-mail in error, please delete it immediately and inform the sender of the=error or contact info@nusi.org <mailto:info@nusi.org>